皇冠登1登2登3:MRGC, UCrest ink deal to integrate genome services into digital platform

皇冠登1登2登3（www.99cx.vip）实时更新发布最新最快最有效的登1登2登3代理网址,包括新2登1登2登3代理手机网址,新2登1登2登3代理备用网址,皇冠登1登2登3代理最新网址,新2登1登2登3代理足球网址,新2网址大全。

The contract involves the supply of the rolling stock, which is hydrogen-powered autonomous rapid transit (ART) vehicles, depot equipment and maintenance vehicles, signalling and control system as well as the automative platform gate.

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd (MGRC) has entered into a service level agreement with Ucrest Bhd to integrate its genome services into the latter's digital health platform, iMedic.

Accordingly, a virtual genome service centre will be developed on iMedic, enabling MGRC's genome services to be made available to the hospitals and clinics, and widen its market access globally.

In a joint statement, the parties said the genome services will also be made available to patients directly.

"The platform will also enable us to strengthen our B2B and B2C channels.

"This collaboration can play an important role in providing physicians with easy access to the latest in genetic screening, in support of enhancing their medical practice and improving patient outcomes," said MRGC CEO Sasha Nordin in a statement.

,

欧博Allbet（www.allbet8.vip）是欧博集团的官方网站。欧博官网开放Allbet注册、Allbe代理、Allbet电脑客户端、Allbet手机版下载等业务。

,

Meanwhile, UCrest CEO Eg Kah Yee said the integration of genome data into iMedic will empower patients to better prevent and manage chronic diseases with the online consultation of doctors.

According to the statement, the agreement is valid for three years and may be extended for a further three years.

Before the midday break, MGRC last traded six sen or 5.22% lower at RM1.09 a share on the back of 18.52 million shares traded.

UCrest was up two sen or 23.53% to 10.5 sen a share with 11.38 million shares crossing hands.

转载说明:本文转载自Sunbet。